23 August 2023
Valbenazine approved by U.S. FDA for treatment of chorea in HD
Neurocrine Biosciences, Inc. announced the U.S. Food and Drug Administration (FDA) has approved INGREZZA ® (Valbenazine) capsules for treatment of
Read more
Huntington DiseaseLearn About Huntington Disease Learn About Our Services |
Connect with us |
Research |
Our Shining StarsRalph Walker Our Founder |
23 August 2023
Neurocrine Biosciences, Inc. announced the U.S. Food and Drug Administration (FDA) has approved INGREZZA ® (Valbenazine) capsules for treatment of
Read more
25 April 2023
Dear Huntington disease (HD) community, We have received an update on PROOF-HD, the phase 3, randomized, double-blind, placebo-controlled study to
Read more
6 April 2023
Do you like feel-good news? We know you’ll love this fabulous Huntington disease (HD) update. Thanks to our generous donors,
Read more
8 December 2022
Update From Novartis Regarding VIBRANT-HD Clinical Trials – December 8, 2022 Dear Huntington disease (HD) community, We have received a
Read more
Our Shining Stars virtual tribute wall honours those who have been touched in some way by HD. Please see our Shining Stars on our Shining Stars Universe, Galaxy and Solar System pages.
The Huntington Society of Canada delivers counselling service to support those living with Huntington disease and to help fund medical research to delay or stop the disease. The Society raises awareness of HD across Canada and works with health and social services professionals to enable them to better serve people living with HD.